PATENT CLAIM ANALYSIS

Application Number: 15982043
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["549", "406000"]

Abstract:
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds: wherein n, m, p, s, t, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 20 , X, Y, Q and Z have defined meanings.

Claim (Index 8):
The compound of  claim 1 , wherein\n R 2  and R 20  are each independently selected from halo, cyano, polyhaloC 1-6 alkyl, C 1-6 alkyl, morpholinyl, C 1-6 alkyloxy, hydroxyC 1-6 alkyl, \u2014NR 21 R 22  wherein R 21  is hydrogen and R 22  is C 1-6 alkylcarbonyl; or R 2  and R 20  together with the phenyl ring to which they are attached form a naphthalenyl group, or one of R 2  or R 20  is as defined above and the other one of R 2  or R 20  together with R 9  form a direct bond.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 93.0
- Lexical Diversity: 1.53061
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12678961', '12938633', '12678680', '11575552', '12293545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8162894123573118
- 35 USC 102 Novelty (BERT): 0.599140407883089
- Combined Prediction Score: 0.7945745119098895
- Mean Citation Score: 491.280192
- Max Citation Score: 504.37778
- Similarity Product: 498.4211061052585

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test